RBRK Form 144 Filing Details: 21,000 Shares to Be Sold via Morgan Stanley
Rhea-AI Filing Summary
Form 144 notice for Rubrik, Inc. (RBRK) reports a proposed sale of 21,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $1,575,000, and an approximate sale date of 09/17/2025. The filing lists that 12,000 shares were acquired by exercise of stock options on 09/17/2025 (paid in cash) and 9,000 shares were issued as restricted stock units on 04/25/2024. The form also discloses periodic 10b5-1 plan sales totaling 21,000 shares during the past three months, with gross proceeds listed for each trade. The filer certifies they are unaware of undisclosed material adverse information.
Positive
- Full disclosure of sale mechanics including broker name, share counts, and aggregate market value
- Use of 10b5-1 plans for prior sales, which indicates prearranged trading instructions and procedural compliance
- Acquisition details provided (option exercise and RSU grant dates) clarifying how the shares were obtained
Negative
- Substantial share dispositions totaling 21,000 shares and $1,575,000 in aggregate value may represent meaningful insider selling pressure
- Relationship to issuer not specified in the provided sections, leaving the filer’s insider status unclear
Insights
TL;DR Proposed sale of 21,000 RBRK shares via broker; recent 10b5-1 sales total same amount in prior months.
The filing documents a proposed public sale of 21,000 common shares through Morgan Stanley Smith Barney LLC valued at $1,575,000, with acquisition details showing both option exercise and RSU issuance. The record of multiple 10b5-1 sales in the prior three months quantifies recent disposition activity and provides transparency on execution method and proceeds. This is a routine insider sale notice rather than a corporate operating disclosure.
TL;DR Use of a broker and 10b5-1 entries suggests compliant, prearranged disposition; filer affirms no undisclosed material information.
The form contains required compliance elements: broker identification, detailed acquisition dates, payment method, and historical 10b5-1 sales with gross proceeds. The filer signs the standard attestation regarding material nonpublic information. There are no disclosures here about issuer financials, regulatory issues, or governance changes that would indicate elevated compliance risk beyond the sales themselves.